Denali Therapeutics Inc. - COM (DNLI)

Q3 2024 13F Holders as of 9/30/2024

Type / Class
Equity / COM
Number of holders
214
Total Shares
126M
Shares change
+5.48M
Total reported value, excl. options
$3.68B
Value change
+$176M
Put/Call ratio
0.39
Number of buys
110
Number of sells
-78
Price
$29.13
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.